The chemical composition of pneumococcal C-polysaccharide.
نویسندگان
چکیده
The species-specific C-polysaccharide of the pneumococcus was first described by Tillett, Goebel, and Avery in 1930 (1). The chemical composition was examined by Heidelberger and Kendall (2) and by Goebel et al. (3) ; the latter study showed that the C-polysaccharide contained 4.47% phosphorus, 5.91% nitrogen, 50.6% reducing sugar, 21.8 % hexosamine, and 13.08% acetyl. Detailed information as to the chemical composition of the polysaccharide was not provided by these early studies, however. It was felt that more thorough understanding of the chemistry of the C-polysaccharide might provide increased knowledge of the structure and metabolic activity of the pneumococcus, and might also shed light on the ability of this polysaccharide to combine with and precipitate the C-reactive protein which appears in human sera during infection. The present report will describe investigations which have demonstrated the presence in the C-polysaccharide of amino sugars and amino acids. The chemical composition thus established indicates that the C-polysaccharide originates from the bacterial cell wall. One constituent of the polysaccharide, galactosamine 6-phosphate, has not been found before in bacterial cell walls.
منابع مشابه
Conjugate and 23-valent pneumococcal polysaccharide booster vaccination in asplenic patients with thalassemia major: A randomized clinical trial study
Background: Pneumococcal vaccine provides protection against invasive pneumococcal disease in population at risk. This study was conducted to compare the antibody response to 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in patients with thalassemia major. Methods: A randomized cross-over clinical trial was performed on 50 asplenic patients with t...
متن کاملImmunogenicity of 23-Valent Pneumococcal Vaccine in Children with Systemic Lupus Erythematosus
Background: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease which is characterized by B-cell abnormality and auto-antibody generation. Since bacterial infections are the most important causes of mortality in these patients, pneumococcal vaccination is recommended for children with SLE. Objective: To investigate humoral immunity and specific-antibody formation in response to a...
متن کاملPneumococcal serotypes and their clinical relevance.
Pneumococcal disease is endemic all over the world. Epidemics may occur, most often in closed institutional settings such as schools and military camps, but account for only a minority of all the cases. The total incidence of pneumococcal pneumonia in Western populations is 1–5 per 1000 person-years, and several times higher in the very young and the elderly. In developing countries it is estim...
متن کاملIn vitro biofilm formation by Streptococcus pneumoniae as a predictor of post-vaccination emerging serotypes colonizing the human nasopharynx.
The increasing use of the 7-valent pneumococcal conjugate vaccine has been accompanied by the rise of non-vaccine serotypes colonizing the human nasopharynx. The vast majority of infections are caused by microorganisms that grow in biofilms. It has recently been shown that the formation of Streptococcus pneumoniae biofilms in vivo and in vitro is hindered by the presence of capsular polysacchar...
متن کاملبررسی تولید آنتیبادی اختصاصی بعد از تزریق واکسن پلیساکاریدی در بیماران با نارسایی مزمن کلیه
Background: An increased risk for invasive infections with encapsulated bacteria such as Streptococcus pneumoniae has been described in patients with chronic kidney disease (CKD) or in those on dialysis. The aim of this study was to evaluate the antibody response to pneumococcal capsular polysaccharide vaccine in CKD patients. Methods: Sixty-six patients with CKD and 40 healthy indiv...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The Journal of biological chemistry
دوره 238 شماره
صفحات -
تاریخ انتشار 1963